Nexalin Technology, Inc.

Analysis for Ticker: NXL

Nexalin Technology Inc is a medical device business that creates neurostimulation headsets meant to stimulate the brain to treat mental health issues like anxiety, insomnia, and depression. While it presents itself as a scientific innovator, the financial reality reveals a machine designed to burn public capital for private gain. Think of it like a business that spends 30$ on electricity and rent just to sell one 1$ cup of coffee. By 12/2025, the company generated only 301.647$ in total revenue while incinerating 8,63$ million in operating expenses. This is not a sustainable enterprise; it is a structural collapse with an accumulated deficit that has reached 92,86$ million. The timeline of this wealth transfer began in 12/2025. In the first nine months of 2025, the company lost nearly 6$ million while making less than 130.000$ from its products. To stay alive, they used a program managed by Maxim Group LLC to print and sell new stock, which caused the number of outstanding shares to jump from 13,3 million in 12/2024 to over 18,1 million shares in a few months. This cash did not go toward research; it went into the pockets of insiders. Chief Executive Officer Mark White acted as his own landlord, using a private company called IIcom Strategic Inc to charge Nexalin Technology Inc tens of thousands of dollars in rent for its Houston office. A former controller, Marilyn Elson, and her husband extracted 16.667$ every month through a consulting firm and were handed hundreds of thousands of dollars in stock awards. The new Chief Financial Officer, Justin Van Fleet, was given a 250.000$ salary to oversee a company that managed to make just 18.149$ in its entire third quarter.